Researchers at one of Victoria’s leading universities, have developed nanotechnology with a seemingly endless capacity for practical application.

Victorian biomedical scientists have published evidence suggesting that a particular antibody could be used to activate a cancer-killing protein.

The next generation of cancer therapies coming out of the ‘Peter Mac’ are a hot topic this week at the International Congress of Immunology.

A Melbourne startup is using its unique workplace philosophy to demonstrate how a business can use it’s diversity to become a global success.

With ageing populations becoming a global trend, the challenge to deliver high quality and cost-effective healthcare is a significant challenge.